Endothelial alterations in hypercholesterolemia: More than simply vasodilator dysfunction

Journal of Cardiovascular Pharmacology

Volumn 32, Issue SUPPL. 3, 1998, Pages

  Tsao, Philip S ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Hypercholesteremia; Nitric oxide; Nitric oxide synthase; Oxygen free radicals

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN RADICAL; QUINAPRIL; SIMVASTATIN;

ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; NITRIC OXIDE; VASODILATION;

EID: 0032417397     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P, ed. Mechanisms of vasodilation. New York: Raven Press, 1988:401-4.
2. Ignarro LJ, Bymes RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987;327:524-6.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
4. Stamler J, Mendelsohn ME, Amarante P, et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-95.
5. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
6. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-77.
7. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endolhelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92:1137-41.
8. Lefer AM. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 1997;95:553-4.
9. Tsao P, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-82.
10. Fukuo K, Hata S, Suhara T, Nakahashi T, et al. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 1996;27:823-6.
11. Sarih M, Souvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 1993;191:503-8.
12. Ross R: The pathogenesis of atherosclerosis. W Engl J Med 1986; 314:488-500.
13. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
14. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488-96.
15. Brown MS, Goldstein JL. Atherosclerosis. Scavenging for receptors. Nature 1990;343:508-9.
16. Verbeuren TH, Jordaens FH, Zonnekeyn LL, VanHove GE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res 1986;58:552-64.
17. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;15:1046-51.
18. Bath PMW, Hassall DG, Gladwin A-M, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteroscler Thromb 1991;11:254-60.
19. Tsao PS, Lewis NP, Alpert SA, Cooke JP. Exposure to shear stress alters endothelial adhesiveness: role of nitric oxide. Circulation 1995;92:3513-9.
20. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via Superoxide and mast cells. FASEB J 1993;7:1293-9.
21. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelialderived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107:1050-8.
22. DeCaterina R, Libby P, Peng H-B, et al. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 1995;96: 60-8.
23. Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow inhibits endothelial adhesiveness: NO and transcriptional regulation of VCAM-I. Circulation 1996;94:1682-9.
24. Marui N, Offerman MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-74.
25. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
26. Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995;270:1421-9.
27. Tsao PS, Wang B-Y, Buitrago R, Cooke JP. Nitric oxide regulates the expression of monocyte chemotactic protein-1. Circulation 1997;96:934-40.
28. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995;76:980-6.
29. Peng HB, Rajavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995;270:17050-5.
30. Cooke JP, Singer AH, Tsao PS, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesteroemic rabbit. J Clin Invest 1992;90:1168-72.
31. Cayette AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994;14:753-9.
32. Naruse K, Shimizu K, Muramatsu M, et al. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Anetrioscler Thromb 1994;14:746-52.
33. Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP. Regression or progression. Dependency on vascular nitric oxide. Anerioscler Thromb Vasc Biol 1996;16:44-50.
34. Weber C, Erl W, Weber KS, Weber PC. HMG-CoA reductase inhibitors decrease CDllb expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 1997;30:1212-7.
35. Theilmeier G, Zalpour C, Ma A, et al. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arterioscler Thromb Vasc Biol 1997;17:3557-64.